Joseph Palumbo
Chief Tech/Sci/R&D Officer bij BIOVIE INC.
Vermogen: 3 930 $ op 31-03-2024
Profiel
Joseph M.
Palumbo is currently the Director at Hydreight Technologies, Inc. and the Chief Medical Officer at BioVie, Inc. He previously worked as the Head-Global & Franchise Medical at Johnson & Johnson, Vice President-US Medical Science at Mitsubishi Tanabe Pharma Corp., and as the Chief Medical Officer & Vice President at Zynerba Pharmaceuticals, Inc. Palumbo holds an undergraduate degree from the University of Pennsylvania Graduate School of Education and a doctorate from George Washington University School of Medicine & Health.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BIOVIE INC. CLASS A
0.01% | 09-08-2023 | 7 430 ( 0.01% ) | 3 930 $ | 31-03-2024 |
Actieve functies van Joseph Palumbo
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOVIE INC. | Chief Tech/Sci/R&D Officer | 01-11-2021 |
| HYDREIGHT TECHNOLOGIES INC. | Director/Board Member | 25-11-2022 |
Eerdere bekende functies van Joseph Palumbo
| Bedrijven | Functie | Einde |
|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01-10-2021 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
| MITSUBISHI TANABE PHARMA CORPORATION | Corporate Officer/Principal | - |
Opleiding van Joseph Palumbo
| University of Pennsylvania Graduate School of Education | Undergraduate Degree |
| George Washington University School of Medicine & Health | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| ZYNERBA PHARMACEUTICALS, INC. | Health Technology |
| BIOVIE INC. | Health Technology |
| HYDREIGHT TECHNOLOGIES INC. | Retail Trade |
| Bedrijven in privébezit | 1 |
|---|---|
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |
